Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein

[Image: see text] Coronavirus disease 2019 (COVID-19) is caused by the newly emerged human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to the highly contagious nature of SARS-CoV-2, it has infected more than 137 million individuals and caused more than 2.9 million...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordoloi, Devivasha, Xu, Ziyang, Ho, Michelle, Purwar, Mansi, Bhojnagarwala, Pratik, Cassel, Joel, Giron, Leila B., Walker, Susanne, Kulkarni, Abhijeet J, Ruiz, Edgar Tello, Choi, Jihae, Zaidi, Faraz I., Wu, Yuanhan, Wang, Shaoying, Patel, Ami, Ramos, Stephanie, Smith, Trevor, Kulp, Daniel, Ugen, Kenneth E., Srinivasan, Alagarsamy, Abdel-Mohsen, Mohamed, Humeau, Laurent, Weiner, David B., Muthumani, Kar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353887/
https://www.ncbi.nlm.nih.gov/pubmed/34396059
http://dx.doi.org/10.1021/acsptsci.1c00058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353887/
https://www.ncbi.nlm.nih.gov/pubmed/34396059
http://dx.doi.org/10.1021/acsptsci.1c00058

Ejemplares similares